{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T18:30:57Z","timestamp":1719858657878},"reference-count":35,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2019.10788","type":"journal-article","created":{"date-parts":[[2019,9,3]],"date-time":"2019-09-03T10:01:35Z","timestamp":1567504895000},"source":"Crossref","is-referenced-by-count":3,"title":["Phenotype of mesenchymal stem cells from patients with myelodyplastic syndrome maybe partly modulated by decitabine"],"prefix":"10.3892","author":[{"given":"Yanbin","family":"Pang","sequence":"first","affiliation":[{"name":"The Second School of Clinical Medical, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suxia","family":"Geng","sequence":"additional","affiliation":[{"name":"Department of Hematology, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongyang","family":"Zhang","sequence":"additional","affiliation":[{"name":"The Second School of Clinical Medical, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peilong","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Hematology, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengjun","family":"Liao","sequence":"additional","affiliation":[{"name":"Department of Hematology, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lingji","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Hematology, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zesheng","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, Guangdong 510080, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianyu","family":"Weng","sequence":"additional","affiliation":[{"name":"The Second School of Clinical Medical, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin","family":"Du","sequence":"additional","affiliation":[{"name":"The Second School of Clinical Medical, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2019,9,3]]},"reference":[{"key":"key20200714091804_b1-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/S0140-6736(13)61901-7","article-title":"Myelodysplastic syndromes","volume":"383","author":"Ad\u00e8s","year":"2014","journal-title":"Lancet"},{"key":"key20200714091804_b2-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1182\/blood-2016-10-696062","article-title":"Stem and progenitor cell alterations in myelodysplastic syndromes","volume":"129","author":"Shastri","year":"2017","journal-title":"Blood"},{"key":"key20200714091804_b3-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.3324\/haematol.2013.083972","article-title":"Mesenchymal stromal cells from patients with myelodyplastic syndrome display distinct functional alterations that are modulatedbylenalidomide","volume":"98","author":"Ferrer","year":"2013","journal-title":"Haematologica"},{"key":"key20200714091804_b4-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.stem.2014.02.014","article-title":"Myelodysplastic cells in patients reprogram mesenchymal stromal cells to establisha transplantable stem cell niche disease unit","volume":"14","author":"Medyouf","year":"2014","journal-title":"Cell Stem Cell"},{"key":"key20200714091804_b5-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.stem.2016.08.021","article-title":"Mesenchymal inflammation drives genotoxic stressin hematopoietic stem cells and predicts diseaseevolution in human pre-leukemia","volume":"19","author":"Zambetti","year":"2016","journal-title":"Cell Stem Cell"},{"key":"key20200714091804_b6-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1038\/nature08851","article-title":"Bone progenitor dysfunction induces myelodysplasia andsecondary leukemia","volume":"464","author":"Raaijmakers","year":"2010","journal-title":"Nature"},{"key":"key20200714091804_b7-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/ni.3002","article-title":"Plasticity of mesenchymal stem cells inimmunomodulation: Pathological andtherapeutic implications","volume":"15","author":"Wang","year":"2014","journal-title":"Nat Immunol"},{"key":"key20200714091804_b8-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3892\/ijo_00000187","article-title":"Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markers","volume":"34","author":"Bagley","year":"2009","journal-title":"Int J Oncol"},{"key":"key20200714091804_b9-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3324\/haematol.2014.109769","article-title":"Down-regulation of Dicer1 promotes cellular senescence and decreases the differentiation and stem cell-supporting capacities of mesenchymal stromal cells in patients with myelodysplastic syndrome","volume":"100","author":"Zhao","year":"2015","journal-title":"Haematologica"},{"key":"key20200714091804_b10-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1038\/leu.2013.193","article-title":"Insufficient stromal support in MDS results from molecular andfunctional deficits of mesenchymal stromal cells","volume":"27","author":"Geyh","year":"2013","journal-title":"Leukemia"},{"key":"key20200714091804_b11-ol-0-0-10788","first-page":"3462","article-title":"Premature exhaustion of mesenchymal stromal cellsfrom myelodysplastic syndrome patients","volume":"9","author":"Pang","year":"2017","journal-title":"Am J Transl Res"},{"key":"key20200714091804_b12-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1089\/scd.2013.0283","article-title":"Impaired proliferative potential of bone marrow mesenchymal stromal cells in patients with myelodysplastic syndromes is associated with abnormal wnt signaling pathway","volume":"23","author":"Pavlaki","year":"2014","journal-title":"Stem Cells Dev"},{"key":"key20200714091804_b13-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.exphem.2015.10.005","article-title":"Impairment of PI3K\/AKT and WNT\/\u03b2-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes","volume":"44","author":"Falconi","year":"2016","journal-title":"Exp Hematol"},{"key":"key20200714091804_b14-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1016\/j.cell.2015.07.056","article-title":"DNA-demethylating agents target colorectal cancer cells by inducing viral mimicry by endogenous transcripts","volume":"162","author":"Roulois","year":"2015","journal-title":"Cell"},{"key":"key20200714091804_b15-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.jphs.2015.03.008","article-title":"Decreased DNA methylation in the promoter region of the WNT5A and GDNF genes may promote the osteogenicity of mesenchymal stemcells from patients with ossified spinal ligaments","volume":"127","author":"Chiba","year":"2015","journal-title":"J Pharmacol Sci"},{"key":"key20200714091804_b16-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.bbrc.2014.08.152","article-title":"Inhibition of DNA methylation enhances HLA-G expression in human mesenchymal stem cells","volume":"452","author":"Teklemariam","year":"2014","journal-title":"Biochem Biophys Res Commun"},{"key":"key20200714091804_b17-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification ofmyeloid neoplasms and acute leukemia: Rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"key20200714091804_b18-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"key20200714091804_b19-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1111\/ejh.12385","article-title":"Senescence of bone marrow mesenchymal stromal cells is accompanied by activation of p53\/p21 pathway inmyelodysplastic syndromes","volume":"93","author":"Fei","year":"2014","journal-title":"Eur J Haematol"},{"key":"key20200714091804_b20-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.ccr.2011.12.029","article-title":"Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells","volume":"21","author":"Tsai","year":"2012","journal-title":"Cancer Cell"},{"key":"key20200714091804_b21-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"e70522","DOI":"10.1371\/journal.pone.0070522","article-title":"Increased PRAME-specific CTL killing of acute myeloid leukemia cells by either a novel histone deacetylase inhibitor chidamide alone or combined treatment with decitabine","volume":"8","author":"Yao","year":"2013","journal-title":"PLoS One"},{"key":"key20200714091804_b22-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"2347","DOI":"10.3892\/ol.2016.4259","article-title":"Effects of decitabine on megakaryocyte maturation in patients with myelodysplastic syndromes","volume":"11","author":"Ding","year":"2016","journal-title":"Oncol Lett"},{"key":"key20200714091804_b23-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200714091804_b24-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"3393","DOI":"10.1182\/blood-2015-02-567453","article-title":"Immune checkpoint blockade in hematologic malignancies","volume":"125","author":"Armand","year":"2015","journal-title":"Blood"},{"key":"key20200714091804_b25-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1016\/j.cell.2017.03.036","article-title":"Inhibiting DNA methylation causes an interferon response in cancer via dsRNA including endogenous retroviruses","volume":"169","author":"Chiappinelli","year":"2017","journal-title":"Cell"},{"key":"key20200714091804_b26-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.biopha.2013.01.004","article-title":"Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2\/M phase through p53-independent pathway in human cancer cells","volume":"67","author":"Shin","year":"2013","journal-title":"Biomed Pharmacother"},{"key":"key20200714091804_b27-ol-0-0-10788","first-page":"11140","article-title":"Decitabine induces G2\/M cell cycle arrest by suppressing p38\/NF-\u03baB signaling inhuman renal clear cell carcinoma","volume":"8","author":"Shang","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"key20200714091804_b28-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13148-016-0237-y","article-title":"A clinical-molecular update onazanucleoside-based therapy for thetreatment of hematologic cancers","volume":"8","author":"Diesch","year":"2016","journal-title":"Clin Epigenetics"},{"key":"key20200714091804_b29-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1182\/blood-2014-04-572255","article-title":"Epigenetic and in vivo comparison of diverse MSC sources reveals an endochondral signature for human hematopoietic niche formation","volume":"125","author":"Reinisch","year":"2015","journal-title":"Blood"},{"key":"key20200714091804_b30-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/nature07547","article-title":"Endochondral ossification is required for haematopoietic stem-cell niche formation","volume":"457","author":"Chan","year":"2009","journal-title":"Nature"},{"key":"key20200714091804_b31-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"431","DOI":"10.18632\/aging.100467","article-title":"Replicatively senescent cells are arrested in G1 and G2 phases","volume":"4","author":"Mao","year":"2012","journal-title":"Aging (Albany NY)"},{"key":"key20200714091804_b32-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1182\/blood-2007-01-067546","article-title":"CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome","volume":"110","author":"Kordasti","year":"2007","journal-title":"Blood"},{"key":"key20200714091804_b33-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"e45675","DOI":"10.1371\/journal.pone.0045675","article-title":"The different immunoregulatory functions of mesenchymal stem cells in patients with low-risk or high-risk myelodysplastic syndromes","volume":"7","author":"Zhao","year":"2012","journal-title":"PLoS One"},{"key":"key20200714091804_b34-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/leu.2013.355","article-title":"Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents","volume":"28","author":"Yang","year":"2014","journal-title":"Leukemia"},{"issue":"pii","key":"key20200714091804_b35-ol-0-0-10788","doi-asserted-by":"publisher","first-page":"E1009","DOI":"10.3390\/ijms17071009","article-title":"Mesenchymal stem and progenitor cells in normaland dysplastic hematopoiesis-masters of survivaland clonality?","volume":"17","author":"Pleyer","year":"2016","journal-title":"Int J Mol Sci"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T09:56:45Z","timestamp":1594720605000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2019.10788"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,3]]},"references-count":35,"URL":"https:\/\/doi.org\/10.3892\/ol.2019.10788","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,3]]}}}